Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "ArtifactAssessment",
"id" : "179698",
"meta" : {
"versionId" : "4",
"lastUpdated" : "2023-12-06T08:41:24.889Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/adaptation"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ArtifactAssessment 179698</b></p><a name=\"179698\"> </a><a name=\"hc179698\"> </a><a name=\"179698-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 4; Last updated: 2023-12-06 08:41:24+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-adaptation.html\">Adaptation</a></p></div><p><b>Artifact Author</b>: Joanne Dehnbostel: </p><p><b>Artifact URL</b>: <a href=\"https://fevir.net/resources/ArtifactAssessment/179698\">https://fevir.net/resources/ArtifactAssessment/179698</a></p><p><b>Artifact Description</b>: </p><div><p>This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data.</p>\n</div><p><b>Artifact Status</b>: active</p><p><b>identifier</b>: FEvIR Object Identifier/179698</p><p><b>title</b>: Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16</p><p><b>artifact</b>: <a href=\"Composition-179466.html\">Recommendation: ADA Obesity Management Recommendation 8.16</a></p><blockquote><p><b>content</b></p><p><b>informationType</b>: Container</p><p><b>type</b>: <span title=\"Codes:\">adapted element</span></p><p><b>classifier</b>: <span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 string-datatype}\">string Datatype</span></p><p><b>path</b>: overallSummary</p><h3>Components</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>InformationType</b></td><td><b>Summary</b></td><td><b>Type</b></td><td><b>Classifier</b></td></tr><tr><td style=\"display: none\">*</td><td>Comment</td><td><div><p>8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A</p>\n</div></td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 OriginalResourceContent}\">Original Resource Content</span></td><td> </td></tr><tr><td style=\"display: none\">*</td><td>Response</td><td> </td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 RationaleForChange}\">Rationale for Change to Resource Content</span></td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 suggested-change}\">Suggested change</span></td></tr><tr><td style=\"display: none\">*</td><td>Change Request</td><td><div><p>8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.</p>\n</div></td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 SuggestedChange}\">Suggested Change to Resource Content</span></td><td> </td></tr></table></blockquote></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail" : {
"name" : "Joanne Dehnbostel"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-url",
"valueUri" : "https://fevir.net/resources/ArtifactAssessment/179698"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-description",
"valueMarkdown" : "This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data."
}
],
"modifierExtension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-status",
"valueCode" : "active"
}
],
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "179698",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"title" : "Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16",
"artifactReference" : {
🔗 "reference" : "Composition/179466",
"type" : "Composition",
"display" : "Recommendation: ADA Obesity Management Recommendation 8.16"
},
"content" : [
{
"informationType" : "container",
"type" : {
"text" : "adapted element"
},
"classifier" : [
{
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "string-datatype",
"display" : "string Datatype"
}
]
}
],
"path" : [
"overallSummary"
],
"component" : [
{
"informationType" : "comment",
"summary" : "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A",
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "OriginalResourceContent",
"display" : "Original Resource Content"
}
]
}
},
{
"informationType" : "response",
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "RationaleForChange",
"display" : "Rationale for Change to Resource Content"
}
]
},
"classifier" : [
{
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "suggested-change",
"display" : "Suggested change"
}
]
}
]
},
{
"informationType" : "change-request",
"summary" : "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.",
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "SuggestedChange",
"display" : "Suggested Change to Resource Content"
}
]
}
}
]
}
]
}
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#2.0.0-ballot based on FHIR 6.0.0-ballot2. Generated 2024-11-21
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change